Cannabis vaping and mental health: The association of Δ‐9‐tetrahydrocannabinol and cannabidiol with anxiety and depressive symptoms—Findings from the United States National Youth Tobacco Survey (2021–2023)

Documenti analoghi

• Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence
  di: Bertrand Redonnet, et al.
  Pubblicazione: (2025)
• RETRACTED: Proportions and correlates of high‐risk cannabis use in Australia—A cross‐sectional analysis of the 2022–2023 National Drug Strategy Household Survey
  di: Janni Leung, et al.
  Pubblicazione: (2025)
• Will Australia's tightened prescription system reduce nicotine vaping among young people?
  di: Wayne D. Hall
  Pubblicazione: (2024)
• Do the differing vaping and smoking trends in Australia and New Zealand reflect different regulatory policies?
  di: Colin Paul Mendelsohn, et al.
  Pubblicazione: (2025)
• Rare but relevant: Cannabinoid hyperemesis syndrome
  di: Daniel Stjepanović, et al.
  Pubblicazione: (2024)